• LAST PRICE
    2.2100
  • TODAY'S CHANGE (%)
    Trending Down-0.1200 (-5.1502%)
  • Bid / Lots
    2.2000/ 8
  • Ask / Lots
    2.4000/ 60
  • Open / Previous Close
    2.3300 / 2.3300
  • Day Range
    Low 2.1700
    High 2.3600
  • 52 Week Range
    Low 1.8101
    High 11.3099
  • Volume
    474,952
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 2.33
TimeVolumeABOS
09:32 ET40622.31
09:34 ET8002.3
09:36 ET1042.31
09:38 ET23002.3
09:39 ET1002.31
09:41 ET64572.3
09:43 ET22552.3
09:45 ET220522.28
09:50 ET27962.26
09:52 ET34212.26
09:54 ET14192.27
09:56 ET3092.27
09:57 ET20002.2676
09:59 ET48992.26
10:01 ET1002.275
10:03 ET7622.27
10:06 ET24122.28
10:08 ET2102.272
10:10 ET1002.275
10:14 ET5002.28
10:17 ET4602.28
10:21 ET1402.28
10:24 ET60002.26
10:26 ET4002.26
10:28 ET2772.265
10:30 ET16052.275
10:32 ET10002.275
10:33 ET21002.27
10:35 ET162402.25
10:37 ET60002.2586
10:39 ET105192.25
10:42 ET29002.2502
10:44 ET62002.25
10:46 ET9602.23
10:48 ET10002.2378
10:50 ET44832.23
10:55 ET23752.225
10:57 ET12242.225
11:00 ET44782.22
11:02 ET11002.22
11:04 ET44502.2211
11:08 ET3002.23
11:09 ET1002.23
11:15 ET1002.22
11:18 ET1002.22
11:22 ET2642.22
11:26 ET19902.22
11:33 ET1002.22
11:36 ET1002.225
11:38 ET1002.23
11:40 ET2002.22
11:42 ET2002.22
11:44 ET3002.22
11:45 ET3002.225
11:47 ET4002.225
11:51 ET1002.2234
11:54 ET1002.22
11:58 ET2002.22
12:02 ET8002.215
12:03 ET57322.22
12:05 ET19422.22
12:07 ET2002.215
12:09 ET2002.21
12:12 ET1002.21
12:16 ET1002.21
12:21 ET5502.22
12:23 ET3502.22
12:25 ET3002.225
12:27 ET2132.22
12:30 ET37012.2306
12:32 ET132152.235
12:34 ET3002.23
12:36 ET40522.245
12:38 ET1152.245
12:39 ET2302.245
12:41 ET10002.24
12:45 ET2502.2301
12:48 ET74702.23
12:57 ET10002.235
12:59 ET1002.23
01:03 ET2002.23
01:08 ET10002.2301
01:10 ET1002.23
01:12 ET31112.225
01:14 ET2002.22
01:19 ET1002.22
01:21 ET3002.22
01:30 ET1002.22
01:32 ET44092.23
01:33 ET9992.2394
01:39 ET3002.235
01:42 ET1002.235
01:44 ET10472.235
01:46 ET1212.23
01:48 ET3002.22
01:51 ET5962.225
01:53 ET1002.22
01:55 ET73002.22
01:57 ET1002.22
02:04 ET1002.2275
02:06 ET1002.225
02:09 ET1002.2235
02:11 ET4002.22
02:13 ET18712.225
02:15 ET15972.22
02:18 ET7242.22
02:22 ET2212.22
02:29 ET2002.225
02:31 ET2252.225
02:36 ET46002.2102
02:40 ET2002.215
02:42 ET26842.215
02:44 ET2002.215
02:45 ET2002.21
02:47 ET3302.215
02:49 ET224582.2
02:51 ET4152.2
02:54 ET64422.2
02:56 ET11112.205
02:58 ET32212.205
03:00 ET182352.195
03:02 ET3402.195
03:03 ET13952.18
03:05 ET12202.175
03:07 ET7452.18
03:09 ET10312.175
03:12 ET5132.17
03:14 ET48352.19
03:16 ET12002.19
03:18 ET34542.18
03:20 ET14992.18
03:23 ET78612.18
03:25 ET4362.185
03:27 ET38052.195
03:32 ET3002.19
03:34 ET18162.18
03:36 ET5002.18
03:38 ET1002.18
03:39 ET6782.18
03:41 ET8552.185
03:43 ET7002.18
03:45 ET18302.185
03:48 ET68932.2
03:50 ET7002.195
03:52 ET106392.21
03:54 ET15052.225
03:56 ET50482.235
03:57 ET75182.235
03:59 ET391082.21
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABOS
Acumen Pharmaceuticals Inc
140.0M
-2.1x
---
United StatesATOS
Atossa Therapeutics Inc
140.8M
-4.7x
---
United StatesKOD
Kodiak Sciences Inc
137.1M
-0.6x
---
United StatesGALT
Galectin Therapeutics Inc
144.8M
-3.3x
---
United StatesVIGL
Vigil Neuroscience Inc
145.5M
-2.0x
---
United StatesCYDY
Cytodyn Inc
133.1M
-2.5x
---
As of 2024-06-20

Company Information

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a disease-modifying approach to target underlying cause of Alzheimer's disease (AD). The Company is focused on focused on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), in clinical development following Phase I results in early AD patients (patients with mild cognitive impairment or mild dementia due to Alzheimer’s pathology). Sabirnetug is a recombinant humanized immunoglobulin gamma 2 (IgG2), monoclonal antibody (mAb) that selectively targets the anti-amyloid-beta oligomer (AbOs), has demonstrated functional and protective effects in in-vitro assays, and has demonstrated in-vivo safety and pharmacologic activity in multiple animal species including transgenic models for AD. The Company is developing sabirnetug for intravenous (IV), administration every four weeks for the treatment of early AD.

Contact Information

Headquarters
427 PARK ST.CHARLOTTESVILLE, VA, United States 22902
Phone
925-368-8508
Fax
302-636-5454

Executives

President, Chief Development Officer
James Doherty
Chief Executive Officer, Director
Daniel O'Connell
Chief Financial Officer, Chief Business Officer
W. Matthew Zuga
Chief Operating Officer
Russell Barton
Chief Legal Officer
Derek Meisner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$140.0M
Revenue (TTM)
$0.00
Shares Outstanding
60.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.05
Book Value
$4.61
P/E Ratio
-2.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.